insights_auto
Why is RCUS up 10,21%?
Dive Deeperchevron_right
RCUS:NYSE
Arcus Biosciences Inc
US$24,40
arrow_upward
+10,21%(+2,26) 1D
20 ຕ.ລ., 14 ໂມງ 35 ນາທີ 13 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RCUS...
Open
US$21,26
High
US$24,70
Low
US$20,81
Mkt. cap
3,11 ຕື້
Avg. vol.
1,71 ລ້ານ
Volume
4,80 ລ້ານ
52-wk high
US$31,74
52-wk low
US$16,41
EPS
US$-3,90
Beta
0,94
Shares outstanding
127,33 ລ້ານ
No. of employees
601
Open
US$21,26
High
US$24,70
Low
US$20,81
Mkt. cap
3,11 ຕື້
Avg. vol.
1,71 ລ້ານ
Volume
4,80 ລ້ານ
52-wk high
US$31,74
52-wk low
US$16,41
EPS
US$-3,90
Beta
0,94
Shares outstanding
127,33 ລ້ານ
No. of employees
601
News stories
From web sources and news partners
GuruFocus
·
30 ນາທີກ່ອນ
Arcus Biosciences (RCUS) Shares Rise on Promising Kidney Cancer Data from ARC-20 Study
Seeking Alpha
·
2 ຊົ່ວໂມງກ່ອນ
Arcus stock rises on ARC-20 data for kidney cancer drug (RCUS)
Investor's Business Daily
·
2 ຊົ່ວໂມງກ່ອນ
Arcus Reverses Course, Surging On Its Merck-Rivaling Cancer Reveal
About Arcus Biosciences Inc